Private Placement

Preclinical data for JUST-AAV shows enhanced brain delivery and reduced side effects, offering new hope for rare neurodegenerative diseases.

Land id's new AI-powered Property Tour goes beyond static PDFs, offering dynamic, data-rich presentations that could change how real estate is sold.

A new platform, SurgeXRP, aims to democratize property investment through tokenization, launching its SGP token presale on the XRP Ledger.

Quince Therapeutics' drug LAM-001 posts strong Phase 2a data, showing meaningful functional gains for patients with severe pulmonary hypertension.

With a new CEO known for scaling operations, TSC Miami signals an aggressive move to dominate the booming on-demand and creator merchandise market.

Alaunos Therapeutics reports positive preclinical data for its oral metabolic drug, but with a perilous financial runway, the race for survival is on.

A strategic investment from Olayan Financing Company positions MS Pharma to dominate the MENA biologics market, fueling Saudi Arabia's Vision 2030 goals.

Amid tourism recovery and new delivery laws, NUGL reports strong Q1 earnings, signaling a new era for Jamaica's burgeoning regulated cannabis industry.

A new law allows VT businesses to fund 100% of green upgrades at no cost to taxpayers, promising a surge in private capital and sustainable development.

South Star Battery Metals upsizes its private placement after strong demand, with its CEO buying the entire first tranche to fund a key graphite project.

The life sciences news hub earned prestigious Neal and Azbee National Gold awards, highlighting the growing influence of expert-driven B2B journalism.

Following seven profitable quarters, Capstone sheds its 'Green' identity for 'Energy+,' pivoting to dominate the booming on-site power market.

A new mixed-income community in Katy leased all 93 units in record time, a stark signal of the urgent, unmet housing demand in a booming Texas region.

With a new $2 billion credit line, investment fund RoboStrategy is poised to accelerate the AI robotics revolution. But can it balance growth with value?

SkyBeam Venture Partners launches a $250M fund, offering global institutions a new, transparent path to Israel's booming early-stage deep tech sector.

The biotech firm raises cash via a complex warrant deal, diluting shares to fund its promising but challenging RNAi therapy for deadly KRAS-driven cancers.

As ARLP heads to a key conference, a tough quarter and a bold diversification strategy put its future in the spotlight for watchful investors.

With an $18M Series A, Arkeus is scaling its AI-powered hyperspectral sensors, giving autonomous military drones unprecedented perception in any environment.

With booming Q1 results and hundreds of new hotels, China's H World Group leverages its lean franchise model for aggressive expansion across Asia Pacific.

A new oral drug for depression shows rapid, robust effects in a key trial, offering hope for millions by targeting a different brain pathway.